Gedeon Richter's Erik Bogsch discusses the company's 100th anniversary, it's growing international footprint and the future of Hungarian pharma.
In Conversation
We understand that you have been with Novo Nordisk for quite a while already. In the past decade, you also did not sit still in terms…
Since establishing Gedeon Richter’s operations here 16 years ago, you’ve been involved in the full array of the pharmaceutical spectrum, from R&D, sourcing API, sales and…
As the 7th largest pharma MNC worldwide, AstraZeneca is a company that needs no introduction. However, our readers would love to hear more about your operations…
How does Janssen view the Serbian market today, and how has company built up its presence here in the country? Previously we were working through distribution…
Novo Nordisk has a long history in Serbia compared to many of the other multinational companies present in the country today. The separate entity Novo Nordisk…
What were the reasons behind the creation of the Cyprus Health Services Promotion Board in 2006 and what have been the main priorities since it was…
Voivodeships, Polish expenditure on health care system per one resident is still below the European average. In regards to the issue concerning the „expenditure on health…
How do you explain that despite the Bolar exemption, a high number of scientists, a very educated population, and Europe’s lowest tax rate, Cyprus has never…
INOVIA was founded in 2007, which is quite recent for a multinational pharmaceutical association. Why was the time right at that point to start INOVIA? There…
Throughout its history, Zdravlje Actavis has grown into one of the 3 companies that really define Serbian pharma. What have been the main factors that got…
From a Zemun-based Belgrade drug manufacturer, Galenika has grown into a leader in Serbia with an increasing footprint worldwide. How would you describe the company today?…
